REBLOZYL Trademark

Trademark Overview

On Thursday, February 9, 2017, a trademark application was filed for REBLOZYL with the United States Patent and Trademark Office. The USPTO has given the REBLOZYL trademark a serial number of 87329959. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, March 28, 2024. This trademark is owned by Celgene Corporation. The REBLOZYL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
reblozyl

General Information

Serial Number87329959
Word MarkREBLOZYL
Filing DateThursday, February 9, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, March 28, 2024
Registration Number5321484
Registration DateTuesday, October 31, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Translation of Words in MarkThe wording "REBLOZYL" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 14, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Monday, February 13, 2017NEW APPLICATION ENTERED
Tuesday, February 14, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 14, 2017ASSIGNED TO EXAMINER
Tuesday, April 18, 2017NON-FINAL ACTION WRITTEN
Tuesday, April 18, 2017NON-FINAL ACTION E-MAILED
Tuesday, April 18, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 21, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 15, 2017ASSIGNED TO LIE
Wednesday, May 17, 2017ASSIGNED TO LIE
Thursday, May 25, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 9, 2017SUSPENSION LETTER WRITTEN
Friday, June 9, 2017LETTER OF SUSPENSION E-MAILED
Friday, June 9, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, June 14, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, June 26, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 26, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2017PUBLISHED FOR OPPOSITION
Tuesday, August 15, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 31, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, January 5, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 5, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 5, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 5, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 5, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 31, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 3, 2023TEAS SECTION 8 & 15 RECEIVED
Thursday, March 28, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 28, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, March 28, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

reblozyl disease pharmaceutical preparations namely inflammation oncology fields immunology cytokine immune